Over 2,000 real rulings β analysed for what they mean to your team. Published every day.
Showing 1914 cases
A GP challenged an Avelox leavepiece headline implying moxifloxacin should be the βfirst choiceβ for concerning chest infections. PMCPA ruled the claim…
Complaint about alleged pre-licence promotion of Herceptin in early breast cancer. Most allegations not upheld, but Appeal Board found a breach where…
Rocheβs CellCept booklet on post-transplant GI complications was challenged by Novartis. Some pages were ruled misleading (data presentation and overall impression) and…
Anonymous employee alleged they were asked to discuss off-label Plavix uses and gather intelligence on an unlaunched competitor. Panel was concerned about…
PMCPA case on clinical trial disclosure for Cyramza. Outcome: no breach and deemed outwith the scope of the ABPI Code (2016). No…
PMCPA Director considered a complaint about clinical trial disclosure for Fycompa. The matter was ruled outwith the scope of the ABPI Code,…
Daiichi-Sankyo admitted three medical staff certified 296 items before their names/qualifications were notified to MHRA and PMCPA. Panel found breaches of Clauses…
Financial Times alleged Novartis delayed disclosure of patient group funding. PMCPA ruled annual report disclosure timing was permitted under Clause 20.3. No…
Media and GP complaints alleged sponsored nurses were incentivised to influence prescribing via free GP audits. PMCPA found Wyethβs GastroCare service was…
MINAP complained a sponsored meeting invite implied MINAP Steering Committee involvement/endorsement. Panel found the invitation misleading and not high standard (Clause 9.1),…
Two Bonviva slide kits were ruled misleading for implying NICE recommended ibandronate and for suggesting nonβvertebral efficacy/class effects. Breaches of Clauses 7.2…
A health professional said Disclosure UK wrongly showed Amgen support. Panel found no breach for 2015 (cause unclear) but breaches for 2016β2017…
Anonymous Roche employees alleged misconduct at a European meeting and excessive call-rate targets. The Panel found no evidence of Code breaches and…
Roche was ruled in breach after Xenical was effectively supplied via a non-HCP at a private clinic and a proposed Β£55,000 clinic…
PMCPA case AUTH/2354/9/10 (Anonymous v Consilient Health) about promotion of oral contraceptives. The matter was ruled outwith the scope of the ABPI…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week β free.